Aim
To describe an evidence-based approach to self-care of mild COVID-19 symptoms

Learning Objectives:
• Describe approaches for preventing the spread of COVID-19
• List symptoms of COVID-19 – similarities and differences to influenza;
• Identify myths associated with self-care of COVID-19.
• Describe how mild symptoms such as fever and pain should be managed;
• Discuss when to refer more serious cases (escalating care in COVID-19).

Target audience – all those involved in the primary health care response to the coronavirus pandemic

Programme:
1. Welcome – Moderator Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation

2. COVID-19: preventing its spread and understanding its symptoms – Jaime Acosta-Gómez, Community Pharmacist and Pharmacy Owner, Spain

3. Dispelling myths about self-care treatments of COVID-19 – Christopher John, FIP Lead for Data and Intelligence

4. How to manage mild symptoms – self-care case study. Lars-Åke Söderlund, President FIP Community Pharmacy Section

5. Panel Discussion – questions and answers – All speakers

In this episode – “Setting Transformation Goals for Vaccination Globally” – is a roundtable discussion that focuses on the role of the FIP Development Goals in the transformation of pharmacist vaccination globally and regionally. The discussion will focus on the development of transformative goals and how these goals will be used to deliver pharmacist vaccinators in all jurisdictions, resulting in increased vaccination rates worldwide.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To summarise and discuss the impact of FIP Development Goals in the Transformation of Vaccination Globally and Regionally.

La inmunización ha hecho una enorme contribución a la salud pública mundial. Recientemente la Federación International Farmacéutica (FIP) realizó una encuesta global sobre el papel de los farmacéuticos en el área de la vacunación. Se evaluaron varias actividades, tales como la promoción de la vacunación, los marcos legales, la administración de vacunas, la capacitación y las barreras existentes. Los datos muestran que existe un papel consolidado y creciente de los farmacéuticos en la vacunación en todo el mundo. Estos resultados y otras publicaciones desarrolladas por la FIP para apoyar a los farmacéuticos y sus organizaciones en esta área se presentarán en este seminario web. 

1) Determinar el papel evolutivo que los farmacéuticos desempeñan en todo el mundo para mejorar la confianza en las vacunas y la cobertura vacunal.

2) Describir la situación actual con respecto a la práctica y la regulación de la farmacia en el área de la vacunación.

3) Distinguir las lagunas y los desafíos que requieren la atención de las organizaciones farmacéuticas para desarrollar los diferentes roles del farmacéutico en inmunización en el futuro.

This event will discuss how the quality, efficacy and safety of vaccines are built into their development and manufacturing processes, including the clinical research they undergo and the strict regulatory assessment that precedes their marketing authorization. In addition, speakers will discuss how to make such processes understood and well-known by the public in a transparent and clear manner, in order to build confidence in vaccines and address the grave problem of vaccine hesitancy and anti-vaccines movements, i.e., the refusal to get vaccinated despite the availability of vaccines.

Learning Objectives:
After this webinar the participants should have a better understanding of the following topics:
1. Vaccine efficacy
2. Vaccine quality and safety assurance.
3. Vaccine hesitancy and how to address it through transparent and evidence-based arguments, and positive examples of the value of vaccines.
4. The role of pharmacists in building vaccine confidence.

Programme: Communicating vaccine safety, building vaccine confidence
Moderator:
- Giovanni Pauletti, FIP’s Scientific Secretary
Chair, Department of Pharmaceutical & Administrative Sciences, St. Louis College of Pharmacy - USA

Speakers:
- Alberta Di Pasquale, Director, Global Medical Affairs Vaccine Science and Medical Education Lead, GSK - Italy/Belgium
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists – Spain

The world’s pharmacy team is fighting COVID-19 in a variety of ways. This webinar will host stakeholders working in various pharmacy sectors and from different geographical regions to share examples and draw on what we can learn in our pursuit of resilience. Research-driven findings will be shared that may aid in developing and advancing resilience within ourselves, for our patients, colleagues and the systems we are a part in our ability to tackle very challenging times. This event is delivered by FIP in collaboration with GRiT – Global Resilience Team, Led by: Dr Karen Whitfield.

The webinar aims to:
- Introduce participants to GRiT - Global Resilience Team ethos; a collaborative team passionate for raising awareness of the importance of developing resilience in our workforce.
- Showcase global perspectives from research and practice related to resilience in pharmacy.
- Share experiences in developing relevant and practical material to build into pharmacy curricula.

Moderator:
- Prof. Zubin Austin, Koffler Research Chair in Management, Leslie Dan Faculty of Pharmacy and Institute for Health Policy, Management, and Evaluation - Faculty of Medicine at the University of Toronto - Canada

Event Chair:
- Dr Catriona Bradley, Executive Director, The Irish Institute of Pharmacy - Ireland

Panellists:
- Dr Karen Whitfield, Associate Professor, School of Pharmacy, The University of Queensland - Australia
- Dr Sarah Wills, Senior Lecturer, The University of Manchester - UK
- Dr Dalia Bajis, Assistant Professor, Mohammed Al-Mana College for Medical Sciences - Saudi Arabia
- Dr Kyle Wilby, Associate Dean (Undergraduate) and Associate Professor, School of Pharmacy, University of Otago - New Zealand
- Dr Vibhuti Arya, Global Lead, Equity and Equality, International Pharmaceutical Federation (FIP) - USA
- Elizabeth Shekalaghe, Registrar /CEO, Pharmacy Council Tanzania - Tanzania